Celeris Therapeutics is a deep learning company that uses innovative methods to degrade undruggable targets. We predict biomolecular interactions and generate small, organic molecules and degraders such as PROTACs against these targets. Celeris Therapeutics' technical solution is the web application Celeris One. Users of the platform are pharmaceutical and biotech companies with a focus on Targeted Protein Degradation. It consists of three modules: Xanthos, Hephaistos and Hades. A team of world-class experts, strong IP, and a global network facilitate the process of treating currently incurable diseases.